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Abstract
It remains unclear what determines the subcellular localization of hepatitis B virus (HBV) core protein (HBc) and particles. To
address this fundamental issue, we have identified four distinct HBc localization signals in the arginine rich domain (ARD) of
HBc, using immunofluorescence confocal microscopy and fractionation/Western blot analysis. ARD consists of four tight
clustering arginine-rich subdomains. ARD-I and ARD-III are associated with two co-dependent nuclear localization signals
(NLS), while ARD-II and ARD-IV behave like two independent nuclear export signals (NES). This conclusion is based on five
independent lines of experimental evidence: i) Using an HBV replication system in hepatoma cells, we demonstrated in a
double-blind manner that only the HBc of mutant ARD-II+IV, among a total of 15 ARD mutants, can predominantly localize
to the nucleus. ii) These results were confirmed using a chimera reporter system by placing mutant or wild type HBc
trafficking signals in the heterologous context of SV40 large T antigen (LT). iii) By a heterokaryon or homokaryon analysis,
the fusion protein of SV40 LT-HBc ARD appeared to transport from nuclei of transfected donor cells to nuclei of recipient
cells, suggesting the existence of an NES in HBc ARD. This putative NES is leptomycin B resistant. iv) We demonstrated by
co-immunoprecipitation that HBc ARD can physically interact with a cellular factor TAP/NXF1 (Tip-associated protein/
nuclear export factor-1), which is known to be important for nuclear export of mRNA and proteins. Treatment with a TAP-
specific siRNA strikingly shifted cytoplasmic HBc to nucleus, and led to a near 7-fold reduction of viral replication, and a near
10-fold reduction in HBsAg secretion. v) HBc of mutant ARD-II+IV was accumulated predominantly in the nucleus in a
mouse model by hydrodynamic delivery. In addition to the revised map of NLS, our results suggest that HBc could shuttle
rapidly between nucleus and cytoplasm via a novel TAP-dependent NES.
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Introduction
Hepatitis B virus (HBV) is an important human pathogen
[1,2,3]. Despite the success of HBV vaccination program in
certain countries [4], there is no nationwide vaccination program
in most endemic areas in Asia and Africa. Vaccine failure and
non-responsive cases are not uncommon [5]. Longer term
treatment of HBV patients with nucleoside/nucleotide analogs
often results in drug resistance [6]. Interferon is expensive and has
notorious side effects. Chronic infection with HBV remains to be a
major etiological factor for cirrhosis, liver failure, and hepatocel-
lular carcinoma [1,2,3].
HBV encodes a 21 kDa core (HBc or capsid) protein, which is
required for reverse transcription [7,8]. This core protein can
assemble into stable icosahedral particles, when the electrostatic
interactions between positively and negatively charged macromol-
ecules at the inner surface of the capsid shell are adequately
balanced [9,10,11]. The intracellular core particles can partition
into nucleus and cytoplasm [12,13]. Clinically, hepatic HBc in
patients with minor hepatitis activity was distributed mainly in the
nuclei. In contrast, in patients with chronic active liver diseases,
hepatic HBc was distributed predominantly in the cytoplasm
[14,15,16,17,18]. Mature cytoplasmic core particles contain
relaxed circle (RC) DNA genome, which needs to be transported
to nucleus for conversion into covalently closed circular DNA
[7,8].
The molecular mechanism of HBc nuclear import has remained
unclear. The arginine rich domain (ARD) at the C-terminus of
HBc 147–183 contains four stretches of clustering arginines (Fig. 1).
The amino acid sequences of these clustering arginines resemble
the structural features of known SR proteins [19] or nuclear
localization signals (NLS) [20,21,22]. As shown in Fig. 1, Yeh et al.
[23] reported that at least two direct repeats of PRRRRSQS
(spanning ARD-III and ARD-IV) are required for nuclear import
of HBc. One copy alone of the sequence PRRRRSQS is not
sufficient for HBc nuclear import. On the other hand, it has also
been reported that ARD-I and ARD-IV are associated with two
independent NLS of HBc in stably transfected mouse NIH3T3
fibroblasts. ARD-I alone, or ARD-IV alone, is sufficient for HBc
nuclear localization [24]. Kann et al. [25] demonstrated that HBc
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permeabilized mammalian cells. NPC binding of HBc capsids was
inhibited by synthetic peptides HBc 158–168 or 165–175,
suggesting that part of ARD-II, ARD-III, and/or ARD-IV, may
contain the potential NLS. To date, the discrepancy of the exact
location of HBc NLS remains to be resolved. Furthermore,
previous studies on this issue were performed in the context of
HBc expression without HBV viral replication [23,24,25]. It is
known that more predominant cytoplasmic HBc tends to be
associated with more active HBV DNA replication
[14,15,16,17,18].
Here, we took a new approach to revisit an old issue of HBc
trafficking by using a Huh7 hepatoma cell line permissive for
active HBV replication. We mapped two co-dependent NLS-I and
NLS-III to new positions containing ARD-I and ARD-III,
respectively. Most interestingly, we disclosed two unexpected
nuclear export signals (NES-II and NES-IV)/cytoplasmic reten-
tion signals (CRS-II and CRS-IV), each of which could function
independently from the other. The same HBc ARD could function
as a CRS or NES, depending on the relative strength between
NLS and NES in the context. Furthermore, we demonstrated here
physical and functional interactions between a cellular factor
TAP/NXF1 and HBc ARD. TAP (Tip associated protein) was
identified by a yeast two-hybrid screen using Tip of herpesvirus
saimiri as bait [26]. As a nucleocytoplasmic shuttling protein, TAP
is also known as a major receptor for bulk mRNP export [27,28].
Our results support the notion that HBc could be shuttling
between nucleus and cytoplasm rapidly and continuously.
Furthermore, the significant reduction of HBV DNA synthesis
by siTAP treatment could offer a new avenue for HBV therapy in
the future. Finally, we discussed about a potential role of HBc
nucleocytoplasmic shuttling in HBV pathobiology, such as acute
exacerbation or spontaneous relapse in HBV chronic carriers.
Materials and Methods
Construction of fifteen arginine-to alanine (R-to-A) HBc
ARD mutants
A total of 15 HBc ARD mutants were constructed by
QuickChange XL Site-Directed Mutagenesis (Stratagene Co.),
using the wild type HBV DNA (subtype ayw) of plasmid
pCH93091 as a template. This plasmid cannot produce precore
and HBeAg, but is replication competent [29]. Arginine-to-alanine
substitutions were introduced into HBc amino acid 151 and 152 of
mutant ARD-I, 157 and 158 of mutant ARD-II, 165 and 166 of
mutant ARD-III, and 173 and 174 of mutant ARD-IV. All
mutants were confirmed by DNA sequencing. Most of these 15
ARD mutants are replication defective by Southern blot analysis
(Fig. 2D; manuscript in preparation), and can be rescued to
replicate to various extents by cotransfection with plasmid pMT-
pol [30], or with plasmid 1903 (a core-deficient HBV genomic
dimer) [31].
Construction of SV40 LT- HBc 147–183
SV40 LT was amplified from pSVTex (a gift from Dr. Won-Bo
Wang) by PCR. The SV40 LT DNA fragment without a stop
codon was then subcloned into the pcDNA3.1(+) expression
plasmid (the original stop codon of SV40 LT was not included in
PCR amplification). An HBc ARD fragment carrying a linker (gly-
gly-ser-gly-gly-ser) and a NheI or KpnI restriction site was
amplified by PCR.
The HBc DNA fragment, which carried a NheI restriction site
and a linker (gly-gly-ser-gly-gly-ser), was cloned to the N terminus
of SV40 LT. An HBc DNA fragment, which carried a KpnI
restriction site and a linker (gly-gly-ser-gly-gly-ser), was cloned to
the C-terminus of SV40 LT. Since the KpnI site encodes glycine
and threonine, the total length of the peptide linker between SV40
LT and HBc ARD should be 8 amino acids. DNA sequencing was
performed to confirm the identity of the chimeric plasmid
construct. The NLS-deficient K128T mutant of SV40 LT was
designed as reported previously [21].
Construction of HIV-1 Rev-HBc 147–183
Plasmid pCMV-Rev (from Dr. Steven Chen) was used as a
parental template. Plasmid pCMV-Rev-HBc 147–183 was
assembled from the CMV promoter, HIV-1 Rev cDNA and
HBc ARD. A KpnI restriction site at the 39 end of HIV-I Rev
cDNA was generated by QuickChange XL Site-Directed
Mutagenesis (Stratagene Co.). An HBc ARD fragment carrying
a KpnI restriction site and a linker (gly-gly-ser-gly-gly-ser) was
amplified by PCR. The HIV-1 NES-defective Rev mutant,
containing L78D/E79L mutations [32,33], was engineered by
PCR mutagenesis. The R-to-A mutants of HBc ARD were also
engineered by PCR, using mismatched primers as detailed
elsewhere [9,10].
Cell culture, transfection, and ELISA
Human hepatoma cell line Huh7 and mouse fibroblast cell line
NIH-3T3 were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) (Invitrogen) containing 10% fetal bovine
Figure 1. The mapped locations of HBc nuclear localization
signals reported in literature are contradictory [23,24,25].
doi:10.1371/journal.ppat.1001162.g001
Author Summary
Chronic infection with hepatitis B virus (HBV) could lead to
cirrhosis and highly malignant liver cancer. At present,
treatment of hepatitis B is not very effective, due to
notorious side effects and drug resistance. The virus can
synthesize a core protein for its own replication. Clinically,
this core protein tends to be more localized to the
cytoplasm when patients’ disease is severe, and more
localized to the nucleus when the disease is mild. To date,
the rules that govern the partition of the intracellular core
protein into nucleus vs. cytoplasm remain unclear. Using 5
independent approaches, we identified the ‘‘entry pass-
port’’ (nuclear localization signal) for the core protein to
enter the nucleus. Surprisingly, we also encountered an
unexpected ‘‘exit passport’’ (nuclear export signal) for the
core protein to exit the nucleus. A host factor coined TAP
can serve as a shuttling bus, which can take passengers
like the core protein by its ticket (exit passport), and assist
it to leave the nucleus. We proposed that this core protein
does not ‘‘park’’ in the cytoplasm. Rather, it is shuttling
continuously between nucleus and cytoplasm, in order to
amplify viral DNA. When we reduced the TAP protein, HBV
replication was dramatically reduced. Our finding could
facilitate drug discovery against hepatitis B.
Nucleocytoplasmic Shuttling of HBV Core
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Lipofectamine2000 (Invitrogen) transfection procedure was
according to manufacturer’s instructions. The MTT cytotoxicity
assay (Promega Co.) and the ELISA of HBsAg (General
Biologicals Cooporation, Taiwan) were according to the vendor’s
protocols.
Antibodies
In general, primary antibodies were diluted 300-fold to 1,000-
fold for IFA experiments, and 1,000-fold to 10,000-fold for
Western blot experiments. These primary antibodies include
rabbit polyclonal anti-HBc antibodies (Dako or our own
preparation from using E. coli-expressed HBc 149 of ayw subtype
as an immunogen). These anti-HBc antibodies can recognize both
full-length HBc 183 and truncated HBc 149 of both ayw and adr
subtype origins by IFA and Western blot analysis (data not shown).
Other antibodies used in this paper include mouse monoclonal
anti-HBc antibody (Hyb-3120, Institute of Immunology, Japan)
[34,35,36], mouse monoclonal anti-alpha-tubulin antibody
(ICON-GeneTex, Taiwan), rabbit polyclonal anti-lamin B1
antibody (ICON-GeneTex, Taiwan), chicken polyclonal anti-
Rev (HIV-1) antibody (ICON-GeneTex, Taiwan), mouse and
rabbit anti-TAP antibodies (Santa Cruz and ICON-GeneTex,
Taiwan), and mouse monoclonal anti-SV40 LT antibody (Abcam).
Secondary antibodies were diluted 200-fold for IFA, and 4,000-
fold for Western blot, including goat polyclonal anti-mouse
horseradish peroxidase (HRP) (Sigma), goat polyclonal anti-rabbit-
HRP (Santa Cruz), goat polyclonal anti-rabbit-Rhodamine
(Sigma), donkey polyclonal anti-mouse-fluorescein isothiocyanate
(Santa Cruz), donkey polyclonal anti-mouse-Rhodamine (Santa
Cruz), and goat anti- chicken-IgY-fluorescein isothiocyanate
(ICON-GeneTex, Taiwan).
Immunofluorescence analysis (IFA)
For immunofluorescent staining, cells were cultured on glass
coverslips (18618 mm), and washed with phosphate-buffered
saline (PBS) three times before fixation with freshly prepared 4%
paraformaldehyde in PBS for 30 minutes at room temperature.
Fixed cells were washed three times again with PBS, and
permeabilized with 0.1% Triton X-100 in PBS for 30 minutes at
room temperature. After the final washing with PBS three times,
HBc was stained with a rabbit anti-HBc antibody (Dako), or a
mouse monoclonal antibody (Hyb-3210; Institute of Immunology,
Japan) which recognizes a capsid conformation-specific epitope
[34]. Other primary and secondary antibodies were used as
described above. After immunostaining, coverslips were mounted
on slides in Prolong Medium containing 49-6-diamidino-2-
phenylindole (DAPI) (Invitrogen). Images were collected using a
Zeiss confocal microscope (LSM 510). Pinholes were set to acquire
optical sections of ,0.8 mm. Images were averaged four times and
processed with Zen 2008 Light Edition Zeiss software.
Fractionation of nucleus and cytoplasm
A ProteoJET Cytoplasmic and Nuclear Protein Extraction Kit
(Fermentas, Canada) was used for preparation of the cytoplasmic
and nuclear fractions following the vendor’s protocol. Briefly,
transfected cells were suspended in the cell lysis buffer, vortexed
for 10 seconds, and incubated for 10 minutes at 4uC. After the
first round of centrifugation at 500g for 7 minutes, the
supernatants were subjected to a second round of centrifugation
at 20,000g for 15 minutes. Supernatants were collected as the
cytoplasmic fractions. The pellets from the first round of
centrifugation were rinsed twice with nuclei washing buffer,
and resuspended in the nuclei storage buffer. The samples of
nuclei in the storage buffer was then added with nuclei lysis
reagent, and allowed incubation for 15 minutes at 4uCw i t h
repetitive vortexing in every 3 minutes. The resulting nuclear
samples were centrifuged at 20,000g for 5 minutes at 4uC, and
the supernatants from the centrifugation were collected as nuclear
extracts.
Western blot analysis
Protein samples were prepared from i) total cell lysates, ii) the
cytoplasmic fraction, and iii) the nuclear fraction. For the
preparation of cytoplasmic and nuclear fractions, the procedure
was as described above. For the preparation of total cell lysates,
2610
5 Huh7 cells at 48 hours posttransfection were harvested and
the cell pellets were lysed in 60 mlo f2 6protein lysis buffer (4%
SDS, 100mM Tris-HCl [pH6.8], 0.2% bromophenol blue, 5% 2-
mercaptoethanol, and 20% glycerol). Approximately 30 ml
aliquots of the 400 ml of cytoplasmic fractions from 2610
6 cells
were mixed with 10 ml4 6 protein lysis buffer before loading on
the SDS-polyacrylamide gel electrophoresis (PAGE). Similarly,
25 ml aliquots of a total of 50 ml nuclear fractions from 2610
6 cells
were mixed with 8 ml4 6protein lysis buffer before loading on gel.
Protein samples were boiled for 10 minutes before SDS-PAGE
and Western blot analysis, and were visualized by enhanced
chemilluminescence (Amersham Biosciences).
Leptomycin B treatment
Approximately 24 hours posttransfection, cells were incubated
for 12 hours with leptomycin B (LMB; Sigma) at a final
concentration of 60 ng/ml, or left untreated in DMEM containing
10% fetal bovine serum, at 37uC in the presence of 5% CO2. Cells
were examined by confocal immunofluorescence analysis.
Figure 2. Subcellular localization of HBc of 15 HBc ARD mutants was evaluated by immunofluorescence assay (IFA) of Huh7 cells,
which had been cotransfected with HBc ARD mutants and plasmid pMT-pol expressing HBV polymerase, using a double-blind
protocol. Fig. 2A. Amino acid sequences of 15 alanine scanning ARD mutants are shown in the left panel. In the right panel, the pattern ‘‘C.N’’
represents cells which exhibited predominant cytoplasmic HBc, with weak or no detectable nuclear HBc. In contrast, the pattern ‘‘N.C’’ represents
cells which exhibited predominant nuclear HBc, with weak or no detectable cytoplasmic HBc. The pattern ‘‘C+N’’ represents a third case when HBc
was present in both cytoplasm and nucleus, with no strong preference for either compartment. A summary of the IFA results of these ARD mutants
revealed that only mutant HBc ARD-II+IV exhibited an apparent phenotype in HBc nuclear targeting (mutant HBc ARD-I+II+IV exhibited a very weak
nuclear targeting phenotype). The average numbers and standard deviations are taken from the results of three independent double-blind
experiments. Fig. 2B. Immunofluorescence assay of Huh7 cells was performed using confocal microscopy. HBc (red), a-tubulin (green), and DAPI
(blue). Fig. 2C. Increased nuclear accumulation of HBc of mutant ARD-II+IV was confirmed by fractionation and Western blot analysis using anti-HBc
antibody. The altered electrophoretic mobility on SDS-PAGE of mutant HBc ARD-I+III, and ARD-II+IV, is likely due to their loss of four arginine residues,
which resulted in an altered charge/mass ratio of the mutant HBc proteins. Fig. 2D. Southern blot analysis of HBV DNA replication of wild type HBV,
mutant ARD-I+III, and mutant ARD-II+IV in Huh7 cells. Both mutant ARD-I+III and mutant ARD-II+IV are completely replication defective by
themselves. However, the replication defect of mutant ARD-I+III and mutant ARD-II+IV can be partially rescued by cotransfection with plasmid pMT-
pol, or plasmid 1903. In the left panel (no cotransfection), all three lanes were derived from the same gel. The first lane of wild type HBV DNA was
overexposed on purpose, in order to visualize any weak bandings in lanes I+III and II+IV, if any. See text for further discussion.
doi:10.1371/journal.ppat.1001162.g002
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Twenty-four hours posttransfection, human Huh7 cells were
trypsinized, and 10
6 Huh7 cells were mixed with 2610
6
untransfected mouse NIH-3T3 cells, before seeding on glass
coverslips (18618 mm) in the 6-cm dish. The coculture was
maintained at 37uC for 18 hours. Cells were then treated with
cycloheximide (Sigma) at 50 mg per ml for 30 minutes prior to
fusion. To induce fusion, cells on the coverslips were then covered
with 50% (wt/vol) polyethylene glycol (PEG) 8,000 (Sigma) in
DMEM for 2 minutes at 37uC. PEG-treated cells were rinsed
three times with PBS, and incubated further for 2 hours in
DMEM containing 10% fetal bovine serum and cycloheximide at
50 mg per ml at 37uC in the presence of 5% CO2 prior to confocal
immunofluorescence analysis.
Homokaryon assays
Huh7 donor cells transfected with pCMV-Rev, pCMV-Rev-
HBc ARD, or SV40 LT-HBc ARD chimera, were seeded on
coverslips (18618 mm) in the 6 cm dish, followed by coincubation
with an equal number of Huh7 recipient cells transfected with
pcDNA-SV40 LT or NES-defective Rev for 18 hours at 37uCi n
the presence of 5% CO2. The rest of procedures were the same as
described above in the heterokaryon assay.
Ethics statement
All animal experiments were conducted under protocols
approved by Academia Sinica Institutional Animal Care &
Utilization Committee (ASIACUC). Research was conducted in
compliance with the principles stated in the Guide for the Care and
Use of Laboratory Animals, National Research Council, 1996.
Hydrodynamics-based transfection
BABL/c mice were purchased from the National Laboratory
Animal Center (Taipei, Taiwan). The mice were fed with standard
chow and water ad libitum. Six- to eight-week old male mice were
used in this study. Groups of two BABL/c mice were injected via
tail vein with 30 mg of HBV DNA of pCH93091 in a volume of
PBS equivalent to 8–10% body weight within 5–7 seconds
[37,38].
Immunohistochemical (IHC) staining of HBV core antigen
Three days after injection, liver samples were collected and
embedded for immunohistochemical staining. The endogenous
peroxidase was inhibited by 3% H2O2/PBS. HBV core antigen
was detected by using rabbit polyclonal anti-HBc antibody (Dako).
Secondary antibody used in IHC was goat polyclonal anti-rabbit
HRP (ICON-GeneTex, Taiwan). Peroxidase stain of brown color
was developed by using 3,39-Diaminobenzidine tetrahydrochloride
(DAB, Sigma, USA) as a substrate. The nuclei of liver sections
were also counterstained with Mayer’s hematoxylin (J.T. Baker,
USA).
Knockdown of TAP by SiRNA
The sequencestargeted bychemically synthesized smallinterfering
RNAs (siRNAs, ON-TARGETplus SMARTpool siRNA (Dharma-
con, USA)) in transient knockdown experiments were shown as
follows : TAP/NXF1 gene (target sequence : GGGAAGUCGUA-
CAGCGAAC; GCGCCAUUCGCGAACGAUU; AAUUGAA-
GUCUGAGCGGGA; CGAUGAUGAACGCGUUAAU). Briefly,
Huh7 cells at about 50% confluence in a 12-well culture dish were
transfected with 500ng of plasmid DNA and 50 pmol of siRNA by
using Lipofectamine2000 (Invitrogen). Approximately 48 hours post-
transfection, cells were harvested and analyzed by IFA or Western
blot analysis. To improve the detection sensitivity by Western blot
analysis, Huh7 cells were cotransfected with siRNA and a plasmid
carrying a puromycin resistance gene (pTRE2pur), followed by
incubation with puromycin at 2 mg/ml for 4 days. The majority of
untransfected cells were removed by puromycin treatment.
Immunoprecipitation
The transfected cells (2610
6) were collected and lysed with
0.5 ml of immunoprecipitation buffer (25 mM Tris pH7.4,
150 mM NaCl, 0.5% NP-40, 1mM EDTA, 5% glycerol, protease
inhibitor cocktail (Roche), and 5mM DTT), and allowed
incubation on ice for 20 minutes with occasional mixing. Cell
lysates were centrifuged at 13000g and 4uC for 10 minutes. The
suspension was transferred to a new tube and mixed with
antibodies, and either with or without RNaseA (200mg/mL,
Merck). The antigen-antibody complex was allowed incubation at
4uC for 90 minutes with gentle rotation before mixing with protein
A sepharose beads (GE Healthcare, USA). The protein A-
antibody-antigen complex was further incubated at 4uC for
90 minutes with gentle rotation. The beads were collected by
centrifugation at 1000g, 4uC for 20 seconds and washed 5 times in
1 ml immunoprecipitation buffer. The 16protein lysis buffer was
added to release the protein from the beads.
Construction of a CMV-TAP expression vector
TAP/NXF1 (nuclear RNA export factor 1 isoform 1; NM_
006362) cDNA fragment was generated by PCR amplification
from a human mammary gland matchmaker cDNA library
(Clontech), using the following DNA primers: a forward primer
carrying a BamHI restriction site, a kozak sequence (gccacc), and
an ATG start codon (59 ggcggatccgccaccatggcggacgaggggaag 39); a
reverse primer carrying an EcoRI site and a TGA stop codon (59
gccgaattctcacttcatgaatgccac39). pcDNA-TAP/NXF1 was con-
structed by insertion of a ,1.9kb BamHI - EcoRI fragment
containing the TAP/NXF1 cDNA into a pcDNA3.1 (+) expression
vector. The TAP/NXF1 cDNA fragment was confirmed by
sequencing.
Southern blot analysis
HBV core-associated DNA from transfected cells was subjected
to Southern blot analysis as previously described using a vector
free HBV DNA probe [9,11]. Quantitation of the intensity of the
images was done with Image J (National Institutes of Health).
Results
Rationale
As described in the Introduction, it remains to be settled where
the NLS of HBc is located (Fig. 1; [23,24,25]). None of the
previous studies was conducted in a system with active viral
replication. To revisit this issue, we used here replication-
competent HBV DNA and replication-permissive human Huh7
hepatoma cells.
Alanine scanning of HBc ARD in three different
experimental settings using a double-blind protocol
As shown in Fig. 2A, we introduced arginine (R)-to-alanine (A)
substitutions at various positions in the ARD of HBc. A total of 15
ARD mutants and the wild type HBV genome were transfected,
respectively, into Huh7 cells in three different experimental
settings: a) co-transfected with an HBV polymerase (pol)
expression plasmid pMT-pol [30]; b) co-transfected with a core-
deficient genomic tandem dimer (plasmid 1903) [31]; c) without
Nucleocytoplasmic Shuttling of HBV Core
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overlaps with the pol open reading frame, mutations in the ARD
of HBc could result in concurrent polymerase mutations. To avoid
the complication from concurrent polymerase mutations, we
provided wild type HBV polymerase in trans in the pMT-pol co-
transfection experiment. Alternatively, we co-transfected ARD
mutants with plasmid 1903, which can produce wild type
polymerase, but no HBc protein, due to the ablation of the
AUG initiation codon of HBc at nt 1903. To compare the
subcellular localizations of HBc in various contexts of HBV DNA
replication, we also transfected ARD mutants alone without
cotransfection with any other plasmids.
To distinguish between HBc, precore, and HBeAg
The subcellular localizations of HBc in transfected Huh7 cells
were evaluated at 36–48 hours post-transfection by immunofluo-
rescence assay (IFA) using anti-HBc specific antibodies. Because
HBc, precore, and HBeAg are immunologically cross reactive, it is
important to distinguish them from each other. In the experi-
mental settings with no cotransfection or with pMT-pol cotrans-
fection, no significant amount of HBeAg can be detected by
ELISA (data not shown). As mentioned in Materials and Methods,
all of these HBc ARD mutants were derived from plasmid
pCH93091, which has a tuncated precore open reading frame,
and thus is deficient in both precore and HBeAg [29].
Furthermore, in addition to the rabbit polyclonal anti-HBc
antibody (Dako, Denmark), we also used a mouse monoclonal
antibody Hyb-3120 [36] in the IFA in Fig. 2B. This antibody can
recognize specific HBc capsid conformation [34,35], and fails to
recognize HBeAg. Consistent results were obtained using either
rabbit anti-HBc antibody (Fig. 2) or mouse Hyb-3120 antibody
(data not shown), indicating that it was HBc, rather than precore
or HBeAg, that was stained positive in IFA.
To avoid more subjective interpretation of the results by IFA,
we coded all the samples before transfection, and scored their
subcellular localizations by examining at least 500 HBc-positive
cells for each sample in a double-blind manner (Fig. 2B). To
confirm the results from IFA, we also performed subcellular
fractionation and Western blot analysis using rabbit anti-HBc
antibodies (Fig. 2C, Materials and Methods).
Only one mutant ARD-II+IV exhibited predominant
nuclear localization of HBc
To our surprise, only mutant ARD-II+IV, out of a total of 15
mutants, exhibited a strong phenotype of nuclear localization of
HBc in approximately 70% of HBc positive cells (Fig. 2A and 2B).
In contrast, wild type HBV and most ARD mutants exhibited
predominantly cytoplasmic HBc, and nuclear HBc was found in
approximately 1% of HBc positive cells. The IFA result of nuclear
accumulation of HBc of mutant ARD-II+IV was confirmed by
Western blot analysis. Mutant ARD-II+IV exhibited more HBc in
the nucleus and less HBc in the cytoplasm (Fig. 2C). Overall,
similar conclusions were obtained in all three experimental
settings. One caveat here is that when cotransfection was with
pMT-pol, we always kept the ratio of plasmids between pMT-pol
and HBc ARD mutant less than 1/5 (w/w). Too much polymerase
tended to trap more HBc in the cytoplasm and attenuated the
phenotype of nuclear accumulation of HBc. On the other hand,
without cotransfection with pMT-pol or p1903, the percentage of
cells exhibiting the N.C pattern tended to be higher than that of
cotransfection experiments. Despite these variations in exact
percentages, the general trend of subcellular distribution of HBc
remained consistent among different experimental approaches.
As shown in the left panel of Fig. 2D, mutant ARD-I+III and
mutant ARD-II+IV, could not replicate by themselves. However,
when an intact polymerase (pMT-pol) or a core deficient replicon
(p1903) was provided in trans, DNA synthesis of both mutants can
be partially rescued (middle and right panels, Fig. 2D). The ‘‘short
DNA phenotype’’ of mutants ARD I+III and ARD-II+IV is
reminiscent of arginine deficiency mutant 164 [11] and mutant
173GG [9]. Due to the ‘‘charge imbalance’’ at the inner surface of
HBc capsids, these mutants could be defective in capsid stability,
RNA encapsidation, and DNA synthesis [9,10,11]. This charge
balance hypothesis is under active investigation in another study,
and will not be elaborated here. While the short DNA patterns of
mutants ARD-I+III and ARD-II+IV were similar to each other
(Fig. 2D), their respective HBc distributions were opposite –
cytoplasmic predominance (C.N) of the former vs. nuclear
predominance (N.C) of the latter (Fig. 2A). In brief, we used three
different experimental settings in Fig. 2D (no cotransfection,
cotransfection with pMT-pol or cotransfection with core-deficient
p1903), and obtained similar results that only the HBc of mutant
ARD-II+IV strongly targeted to the nucleus (Fig. 2A).
Data analysis and interpretations
The motif of NLS is known to contain clustering basic residues
[20,21,22]. The fact that mutations at ARD-II and ARD-IV can
promote nuclear localization of HBc suggests that HBc NLS
cannot be located at ARD-II and ARD-IV. Instead, ARD-II and
ARD-IV probably are associated with an ‘‘anti-NLS signal’’
inhibitory to HBc nuclear localization. By inference, we
hypothesize that a putative NLS of HBc could be associated with
ARD-I and ARD-III. Indeed, when mutant ARD-II+IV acquired
a third mutation at either ARD-I (i.e., mutant ARD-I+II+IV) or
ARD-III (i.e., ARD-II+III+IV), nuclear localization of HBc was
almost completely lost (Fig. 2A). This phenomenon suggests that a
putative NLS around ARD-I and ARD-III must function in an
inter-dependent (co-dependent) or bipartite manner, rather than
in an independent manner. According to this scenario, all
genotypes with a mutation at ARD-I or ARD-III would be
predominantly cytoplasmic (Fig. 2A). Furthermore, since neither
single mutant ARD-II nor single mutant ARD-IV is sufficient for
nuclear accumulation of HBc (Fig. 2A), we speculate that the anti-
NLS signals associated with ARD-II and ARD-IV could each
function in a dominant and independent manner.
Rationale
We wish to test further the hypothesis that ARD-I and ARD-III
contain putative NLS, while ARD-II and ARD-IV contain signals
inhibitory or opposite to NLS. To this end, we examined the
respective functions of HBc ARD-I, -II, -III, and -IV, in a
heterologous context of SV40 large T (LT) antigen as a reporter.
Unlike the HBV replication system used in Fig. 2, the SV40 LT
reporter system has no active HBV replication.
SV40 large T antigen-HBc ARD reporter
SV40 large T antigen contains a potent NLS and is localized
predominantly in the nucleus (panel a, Fig. 3B; [20,21,22]). We
constructed a chimeric reporter by in-frame fusion between wild
type SV40 LT and HBc ARD (HBc 147–183). HBc ARD was
positioned at either the C-terminus (Fig. 3A) or N-terminus of
SV40 LT (data not shown). The results of HBc ARD-SV40 LT are
similar to those of SV40 LT-HBc ARD, and therefore, only the
latter is shown here. As shown in Fig. 3B, panel b, while
approximately 55% of the cells remained to exhibit exclusive
nuclear SV40 LT, the other 45% of transfected cells exhibited a
‘‘C+N’’ pattern with SV40 LT present in both nucleus and
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LT was observed when ARD-III contained two arginine-to-
alanine (R-to-A) substitutions (Fig. 3B, panel c). Interestingly,
when R-to-A mutations were introduced into both ARD-II and
ARD-IV of HBc, SV40 LT was again found exclusively in the
nucleus in 100% of transfected cells (Fig. 3B, panel f). The
redistribution of SV40 LT from cytoplasm back to nucleus was not
100% when mutations were introduced into ARD-II alone, or
ARD-IV alone (Fig. 3B, panel d and e). These results here lend a
strong support for the hypothesis that ARD-II and ARD-IV are
associated with anti-NLS like activity. Furthermore, such anti-
NLS like activities of ARD-II and ARD-IV appeared to function
in a dominant and independent manner (i.e., either one alone is
sufficient to inhibit or override NLS). To confirm the results of IFA
in Fig. 3B, we performed fractionation and Western blot analysis
(Fig. 3C). Indeed, the signal of SV40 LT in the nucleus is relatively
stronger for SV40 LT-HBc ARD II+IV (lane f of nuclear fraction,
Fig. 3C) than other chimeras (SV40 LT-HBc ARD-II and SV40
LT-HBc ARD-IV in lanes d and e, Fig. 3C). This can even be
better appreciated when considering the banding intensity of the
total cell lysates (C+N) of mutant ARD-II+IV is relatively weaker
(lane f of C+N panel, Fig. 3C). The weaker signal of the steady
state level of the chimeric protein of SV40 LT-HBc ARD-II+IV
could result from a difference in antibody recognition or protein
half lives. For the detection of the phenotype of nuclear
accumulation of HBc (N.C pattern), IFA in general appeared
to be a more sensitive method than Western blot analysis.
NLS-defective SV40 large T antigen-HBc ARD reporter
As shown in Fig. 2, ARD-I and ARD-III are likely to be
associated with a putative NLS. To test further this association, we
ablated the NLS of SV40 LT by a K128T mutation (Fig. 3D;
[21]). As shown in the IFA of panels a and b, Fig. 3E, NLS-
defective SV40 LT is almost exclusively cytoplasmic, with or
without a fused HBc ARD. However, when the NLS-defective
SV40 LT is fused in-frame with HBc ARD with intact ARD-I and
Figure 3. Fig. 3A–3C: Both HBc ARD-II and ARD-IV can independently contribute to cytoplasmic localization of SV40 large T
antigen. The definitions of the patterns ‘‘N.C’’, ‘‘C.N’’, and ‘‘C+N’’ are as described in the legend to Fig. 2. Fig. 3B. Immunofluorescence assay of
wild type and various chimeric SV40 LT fused in-frame with wild type or mutant HBc ARD, as illustrated in Fig. 3A. Approximately 300 to 500 cells for
each construct were scored for their subcellular localization of SV40 LT. SV40 LT (green), lamin B1 (red), and DAPI (blue). The control sample is from
mock transfected Huh7 cells. Fig. 3C. Western blot analysis of various chimeric SV40 LT is illustrated in Fig. 3A. Fig. 3D–3F: Both HBc ARD-I and ARD-
III are required for nuclear localization of NLS-deficient SV40 LT (mutant K128T). When the NLS of SV40 LT was abolished by mutation K128T, 100% of
cells displayed cytoplasmic LT (C.N pattern). In contrast, approximately 54% of cells transfected with plasmid SV40LT (K128T)-HBc ARD-II+IV shifted
from cytoplasm to nucleus (12% N.C+42% C+N pattern). Fig. 3E. Immunofluorescence assay of various chimeric SV40 LT (NLS-defective) as
illustrated in Fig. 3D. Fig. 3F. Western blot analysis of various chimeric SV40 LT (NLS-defective) as illustrated in Fig. 3D. The weak bandings of SV40LT
at lanes b, c, and d in the nuclear fraction are likely from the residual contamination from the cytoplasmic fraction.
doi:10.1371/journal.ppat.1001162.g003
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SV40 LT was relocalized to nucleus in 54% of transfected cells
(12% N.C and 42% C+N; Fig. 3D). This result suggests that
ARD-I and ARD-III could be associated with a less potent NLS,
which can partially substitute for a more potent NLS native to
SV40 LT, albeit the rescue is not 100% (Fig. 3E, panel e).
Alternatively, the relatively weaker NLS of HBc could be related
to its serine phosphorylation at HBc ARD (unpublished results).
Furthermore, an intact ARD-I alone, or an intact ARD-III alone,
is not sufficient for the NLS-like activity (panels c and d, Fig. 3D
and 3E), indicating that both ARD-I and ARD-III are required for
the NLS-like activity. Most likely, the NLS activity of ARD-I and
ARD-III must act together, co-dependently or synergistically.
Western blot analysis confirmed the results by IFA that a stronger
banding signal of the chimera protein of NLS-defective SV40 LT-
HBc ARD-II+IV was accumulated in the nucleus (lane e, nuclear
fraction, Fig. 3F).
HBc ARD can behave like a cytoplasmic retention signal
(CRS) by homokaryon and heterokaryon analyses
To analyze further the anti-NLS activity of HBc ARD, we
tested by homokaryon analysis (Fig. 4), whether such an anti-NLS
activity could indeed function like a so-called cytoplasmic
retention signal (CRS), as reported for ApoBEC3G and cyclin
B1 in literature [39,40]. We transfected Huh7 cells with pCMV-
Rev, before fusion with Huh7 cells transfected with SV40 LT. By
IFA (upper panel, Fig. 4), we observed nuclear localization of Rev
(green color) in Huh7 cell nuclei with and without expressing
SV40 LT (red color). This result indicates that nuclear import of
Rev into Huh7 cell nuclei expressing SV40 LT can occur
efficiently in the homokaryons. In contrast, no co-localization of
Rev and SV40 LT proteins was observed, when Rev was fused in-
frame with HBc 147–183 (lower panel). These results in Fig. 4
reinforced the previous conclusion that HBc ARD can inhibit or
override the NLS-mediated nuclear import, suggesting that HBc
ARD could behave like a CRS [39,40]. This result was also
confirmed by heterokaryon analysis using human Huh7 cells and
mouse NIH3T3 cells (Supporting Information Figure S1).
HBc ARD can behave like a nuclear export signal (NES) by
homokaryon and heterokaryon analyses
Rationale. We detected anti-NLS or CRS-like activity
associated with HBc ARD-II and ARD-IV (Fig. 2–4). It is
theoretically possible that this phenomenon associated with HBc
ARD could reflect the existence of a potent nuclear export signal
(NES) [41,42] in ARD-II and ARD-IV. For example, if the
strength of an NES can outweigh that of an NLS within the same
protein molecule, then this protein at a steady state could appear
to reside in the cytoplasm, even though it could actually be
shuttling rapidly between the nucleus and cytoplasm in a dynamic
manner.
We performed homokaryon analysis by cell-cell fusion between
Huh7 donor cells transfected with SV40 LT and Huh7 recipient
cells transfected with NES-deficient Rev. Both SV40 LT and
NES-deficient Rev are localized exclusively to the nucleus. We had
examined at least a total of 60 homokaryons for each chimeric
construct in Fig. 5. We observed no transport of SV40 LT (green)
to nuclei expressing NES-deficient Rev (red), and vice versa (panel
a, Fig. 5). In contrast, when SV40 LT was fused with HBc ARD,
we detected co-localization of SV40 LT (green) and NES-deficient
Rev (red) in the same nucleus (yellow), suggesting the transport of
SV40 LT-HBc ARD chimeric protein from one donor nucleus
into another recipient nucleus (panel b, Fig. 5; also cf Supporting
Information Figures S2 and S3). We could observe this kind of
binucleated pattern (one green nucleus and one yellow nucleus) in
approximately 50% of homokaryons. A similar phenomenon of
shuttling between nuclei can be observed when SV40 LT was
fused with HBc ARD-I+III+IV (i.e., ARD-II is structurally intact)
or HBc ARD-I+II+III (i.e., ARD-IV is structurally intact) (panels c
and d, Fig. 5). However, when SV40 LT was fused with HBc
ARD-II+IV, no yellow nuclei were ever detected, indicating the
lack of nucleocytoplasmic transport between nuclei (panel e, Fig. 5;
also cf Supporting Information Figure S4). Similar results were
obtained using a heterokaryon analysis (Supporting Information
Figures S2, S3 and S4). An alternative interpretation of Fig. 5e is
that the donor and recipient cells are adjacent to each other, but
not truly fused into a homokaryon, and thus shuttling between
these two nuclei separated by their plasma membranes was not
possible. This interpretation is unlikely since we examined a total
of 50–60 ‘‘homokaryons’’ in each experiment, and scored zero
shuttling by SV40 LT-HBc ARD-II+IV in several independent
experiments. It should be noted that the negative results in Fig. 5e
was controlled by the positive results in Fig. 5b, 5c, and 5d.
Overall, these results of homokaryon and heterokaryon analyses
strongly suggest the existence of two independent NES-like signals
associated with ARD-II and ARD-IV, respectively. The combined
results of Fig. 4 and 5 indicate that the same HBc ARD in different
contexts (SV40 LT vs. Rev) could behave differently (NES vs.
CRS) (Supporting Information Figure S3). We speculate here that
the relative strength between an NLS and an NES could
determine the trafficking behavior and steady state residence of
a protein.
Figure 4. Homokaryon analysis demonstrated that HBc ARD
domain (HBc 147–183) can act like a cytoplasmic retention
signal (CRS) by inhibiting nuclear import of Rev of Huh7 cells.
Upper panel, Human Huh7 cells were transfected with pCMV-Rev
(green) before fusion with Huh7 cells expressing SV40 LT (red). Lower
panel, Human Huh7 cells were transfected with pCMV-Rev-HBc ARD
(green) before fusion with Huh7 cells expressing SV40 LT (red). DAPI
(blue). No nuclear Rev signal was detected.
doi:10.1371/journal.ppat.1001162.g004
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The prototype NES is known to be sensitive to leptomycin B
(LMB), and is often rich in leucine residues [43,44]. Upon
treatment with leptomycin B, cytoplasmic Rev disappeared in
Huh7 cells transfected with wild type Rev, and all the Rev signals
became localized in the nuclei by IFA (panel a, Fig. 6). However,
in the case of HBc ARD, there is no leucine rich motif. In contrast
to Rev, SV40 LT is known to have a potent NLS, but without any
NES. Therefore, the subcellular localization of SV40 LT should
be independent from LMB treatment (data not shown). When
SV40 LT was fused in-frame with HBc ARD, approximately 50%
of transfected cells exhibited both nuclear and cytoplasmic protein
of SV40 LT-HBc ARD chimera (C+N pattern). Upon treatment
with LMB, no significant change in the percentage of cells
exhibiting a C+N pattern, or an N.C pattern, was ever noted
(panel b, Fig. 6). This result indicates that the NES-like activity of
HBc ARD is leptomycin resistant and Crm-1 independent [43,44].
Specific physical and functional interaction between HBc
ARD and TAP
Our studies here strongly suggest that ARD-II and ARD-IV
could behave like a CRS or NES (Fig. 2–5). In contrast to the
prototypic Crm-1 dependent and leucine-rich NES motif, ARD-II
and ARD-IV contain arginine-rich NES-like motifs. Recently, a
cellular factor TAP has been reported to be essential for the
nuclear export of mRNA and proteins by its physical association
with an NES rich in arginine residues [27,45].
Physical interaction between TAP and HBc ARD
To test the possibility that the NES-like activity of ARD-II and
ARD-IV could be TAP dependent, we examined the potential
interaction between TAP and HBc ARD by immunoprecipitation
and Western blot analysis (Fig. 7A). Our initial attempt to look for
the association between wild type full-length HBc and TAP was
not successful (data not shown), probably due to the fact that the
ARD tail of wild type HBc tends to be buried inside the capsid
interior [46]. As an alternative approach, Huh7 cells were
transfected with either plasmid SV40 LT or plasmid SV40 LT-
HBc ARD, and cell lysates were immunoprecipitated with an
antibody specific for SV40 LT. TAP protein, as visualized by
Western blot analysis, can be coimmunoprecipitated from cell
lysates transfected by plasmid SV40 LT-HBc ARD, but not by
plasmid SV40 LT. In a reciprocal experiment, similar results were
obtained when anti-TAP antibody was used for coimmunopreci-
pitation (Fig. 7A). Furthermore, the physical association between
SV40 LT-HBc ARD and TAP proteins was resistant to RNase
treatment (data not shown). These results suggest that the exposed
HBc ARD and TAP can bind directly to each other in vivo.
Figure 5. Homokaryon analysis revealed the existence of two independent NES-like signals in HBc ARD-II and ARD-IV. Huh7 donor
cells transfected with various versions of SV40LT-HBc chimera (green) were fused with Huh7 recipient cells transfected with NES-deficient Rev (red).
DAPI (blue). a) SV40 large T antigen is localized exclusively to the nucleus. There was no transport of SV40 LT from donor to recipient nuclei. b)
Chimeric protein of SV40 LT-HBc appeared to shuttle from donor to recipient nuclei. c) Mutant HBc ARD-I+III+IV contains an intact subdomain ARD-II.
When this mutant ARD-I+III+IV was fused with SV40 LT, shuttling appeared to occur via the intact ARD-II. d) Mutant HBc ARD-I+II+III contains an intact
subdomain ARD-IV. When this mutant ARD-I+II+III was fused with SV40 LT, shuttling appeared to occur via the intact ARD-IV. e) No apparent shuttling
was observed for mutant ARD-II+IV, when both ARD-II and ARD-IV subdomains were inactivated. This consistent negative result was based on the
examination of a total of 50–60 homokaryons in each experiment, and was controlled by the positive results in panels 5b, 5c, and 5d. Similar results
were obtained using a heterokaryon analysis (Supporting Information Figure S4).
doi:10.1371/journal.ppat.1001162.g005
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accumulation of wild type HBc and significantly reduce
HBV DNA synthesis
In addition to the physical interaction between TAP and HBc
ARD, functional interaction between these two proteins was
demonstrated by TAP-specific siRNA treatment and IFA. As
shown in panel a, Fig. 7B, upon treatment with a control siRNA
Nontarget, more than 70% of transfected Huh7 cells exhibited
HBc signals predominant in the cytoplasm by IFA, and only about
3% of cells exhibited nuclear dominant HBc. In sharp contrast,
upon treatment with a TAP-specific siRNA, only approximately
0–4% of cells exhibited HBc predominant in the cytoplasm, and
approximately 52% of cells exhibited the nuclear dominant HBc
pattern (panel b, Fig. 7B). We noted that whenever the signal of
nuclear HBc was stronger, a rim-like structure around the nuclear
periphery was observed. We speculated that HBc was accumulated
near NPC, and unable to exit due to the lack of TAP. The
reduction of the endogenous TAP protein upon treatment with
siTAP can be demonstrated by Western blot analysis (Fig. 7C).
Because of the limitation of the transfection efficiency of Huh7
cells, the reduction of the TAP protein level in transfected cells
may not be easily detectable in the total cell lysates including both
transfected and untransfected cell populations. To circumvent this
problem, siTAP was cotransfected with a plasmid carrying
puromycin resistance. Treatment of transfected Huh7 cells with
puromycin after transfection indeed helped to enrich the
transfected cell population, and improved the detection sensitivity
by Western blot analysis using a rabbit anti-TAP antibody
(Fig. 7C). Furthermore, nuclear accumulation of HBc induced
by siTAP can be reverted to a cytoplasmic dominant pattern by
cotransfection with a CMV-TAP expression vector (Fig. 7D). This
expression vector produced a TAP specific protein recognized by
anti-TAP antibody in Western blot analysis (Fig. 7E). These results
indicate that there is no off-target effect of siTAP on HBc nuclear
accumulation. In Rev transfected Huh7 cells, no difference in Rev
distribution by IFA was observed between treatments with siTAP
vs. siNontarget (Supporting Information Figure S5), indicating
that siTAP has no significant effect on Crm-1 dependent nuclear
export of Rev. Most importantly, this result also argues against the
possibility that the nuclear accumulation of HBc induced by siTAP
treatment could be the consequence of a non-specific effect of
siTAP.
As mentioned in the Introduction, cytoplasmic predominant
pattern of HBc distribution is often associated with disease activity
and more active viral replication [14,15,16,17,18]. We therefore
asked if siTAP treatment, which resulted in HBc accumulation in
the nucleus, could have any effect on HBV replication. As shown
in Fig. 7F, siTAP reduced HBV DNA synthesis by at least 7-fold,
as well as the HBsAg level in the media by approximately 10-fold,
relative to mock or siNontarget controls. Not only HBV DNA
synthesis can be reduced by siTAP in a dose dependent manner,
but also the reduction of HBV DNA can be significantly rescued
by cotransfection with a CMV-TAP (data not shown). In contrast,
no apparent effect from siTAP on cytotoxicity was detected by
MTT assay (Fig. 7F). Taken together, a drastic shift of wild type
HBc from cytoplasm to nucleus can be triggered by the reduction
of TAP protein. This result supports that nuclear export of HBc
could be mediated through TAP, and nuclear accumulation of
HBc is associated with less active viral replication
[14,15,16,17,18]. One interpretation of the Southern results is
that nuclear accumulation of HBc is a direct cause of reduced viral
DNA synthesis. An alternative explanation is that TAP knock
down could somehow inhibit viral DNA synthesis independent of
HBc nuclear retention. For example, if the reduction of TAP could
lead to the reduction of mRNA export of liver transcription
factors, then the reduction of viral DNA synthesis could primarily
originate from a reduced level of viral transcription.
Hydrodynamic delivery in the mouse animal model
In addition to Huh7 cell culture, we used the hydrodynamic
delivery system to introduce HBV DNA into mouse hepatocytes
[37,38]. Sectioned liver samples collected on day 3 post-injection
were fixed and stained immunohistochemically, and the subcel-
lular distribution of HBc was scored under microscope in a double
blind manner.
As shown in Table 1, approximately 50% of hepatocytes
transfected with wild type HBc exhibited the C+N pattern on day
3 post-injection. The remaining 50% of transfected cells were
about equally split between the C.N pattern and the N.C
pattern. An example of wild type HBc exhibiting the C.N pattern
and C+N pattern on day 3 post-injection is shown in Fig. 8a.
Plasmids of mutants ARD-II+IV and ARD-I+III are based on an
HBV replicon pCH93091 [29]. Both ARD mutants are replication
defective (Fig. 2D). In the sectioned liver, mutant HBc ARD-I+III
exhibited a subcellular distribution profile similar to that of wild
type HBc, with a predominant C+N pattern, and a slightly
reduced percentage of the N.C pattern (Table 1). An example of
HBc subcellular distribution of mutant ARD-I+III exhibiting the
C+N pattern and C.N pattern is shown in Fig. 8b. In contrast,
mutant HBc ARD-II+IV exhibited a nuclear predominant HBc
pattern (N.C, 45.77–64.07%, Table 1) (Fig. 8c and 8d) and the
lowest percentage of C.N pattern (7.30–8.56%). Taken together,
the results from the Huh7 cells in culture did not seem to parallel
very well with that of the hydrodynamic approach using the mouse
model (Fig. 2A vs. Table 1). This is particularly true considering
the N.C pattern of wild type HBc in culture is only around 1%
(Fig. 2A), while the N.C pattern of wild type HBc in vivo using the
hydrodynamic approach is around 26% (Table 1). Despite this
difference in the percentages of subcellular distribution patterns of
Figure 6. Wild type HBc ARD is leptomycin B resistant,
suggesting that HBc ARD does not contain a CRM-1 dependent
NES. Immunofluorescence assay of Rev or SV40 LT-HBc ARD signals
was performed using transfected Huh7 cells with or without leptomycin
B treatment. Rev and SV40 LT (green) and DAPI (blue). a) Wild type Rev
in Huh7 cells exhibited both nuclear and cytoplasmic Rev (left panel,
mock). Upon treatment with leptomycin B, cytoplasmic Rev was lost
(right panel). b) When SV40 LT was fused with wild type HBc ARD, SV40
LT was distributed in both cytoplasm and nucleus in approximately 50%
of transfected Huh7 cells (Fig. 3A). The percentage of cells exhibiting
this C+N pattern of SV40 LT was not affected upon treatment with
leptomycin B for 12 hrs (data not shown).
doi:10.1371/journal.ppat.1001162.g006
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HBc ARD mutants are entirely consistent between the cell culture
and the mouse model (for the N.C pattern, HBc ARD-I+III ,
wild type HBc%HBc ARD-II+IV). The results from the
hydrodynamic studies (Table 1) lend support for the cell culture
studies that ARD-II and ARD-IV are associated with anti-NLS/
CRS/NES activity, while ARD-I and ARD-III are associated with
NLS activity (Fig. 2–6).
Discussion
Comparisons between our current study and previous
reports in literature
As shown in Fig. 9, the results from this study are very different
from those in the literature in two major ways: 1) We identified
two independent CRS/NES-like elements in HBc ARD-II and
ARD-IV which have not so far been reported. 2) We identified two
co-dependent NLS-I and NLS-III which have not been reported
previously [23,24,25]. In the report by Kann et al. [25], the study
of nuclear import was based on a cell-free nuclei system without
cytoplasm. Such a system was designed for the assay of nuclear
import, but not for nuclear export. The reports by Yeh et al. [23]
and Eckhardt et al. [24] were based on the cell culture system.
However these reports were published in 1990 and 1991, at a time
before NES was better known [41,42]. Naturally, earlier studies
were focused only on NLS, but not NES. As for the differences in
the mapped positions of HBc NLS, they are likely due to the
differences in the respective assay systems, e.g., in vitro [25] vs. in
vivo [23,24], and stable [24] vs. transient [23] transfections. Part of
the approach by Eckhardt et al (1991) relied on stable transfection
of mouse NIH3T3 cells using an expression vector of intact or
truncated HBc. Deletion at the HBc ARD could include both
arginines and adjacent serines. It is well known that serine
phosphorylation could influence the trafficking behavior of HBc
[25,47,48]. In our approach (Fig. 2–Fig. 8), serine residues and the
total length of HBc were both preserved in the native context.
Eckhardt et al. [24] reported that a single copy of arginine rich
motif (ARD-I or ARD-IV) is sufficient for nuclear localization of
HBc. In contrast, Yeh et al. [23] reported that at least two copies
of arginine rich motif are required for nuclear localization of HBc.
Our current finding supports the notion that two copies (both
NLS-I and NLS-III) are required for efficient nuclear localization
of HBc (Fig. 9).
Recently, Weigand et al. [49] reported that the HBc ARD
contains no NLS using a GFP-HBc chimeric reporter assay. This
is in contradiction with existing literature and our current findings
of NLS-I and NLS-III. Furthermore, Weigand et al. [49] reported
that a capsid-assembly dependent NES is present in HBc ARD. In
contrast, the NES/CRS identified in our Rev or SV40 LT
chimeric reporter systems are without capsid assembly (Fig. 3 and
data not shown). It is less clear what an NES can be used for, if no
NLS can be used for nuclear import by a cytoplasmic protein. It
might also be useful to distinguish the possibility of co-assembly of
GFP-HBc and wild type HBc from that of co-packaging of GFP-
HBc inside the capsids of wild type HBc [49].
The paradox of functional diversity with structural
identity
It is intriguing that the amino acid sequences of these four ARD
subdomains are strikingly similar, yet their associated functions
Figure 7. Specific physical and functional interactions between a cellular TAP protein and HBc ARD were shown by experiments of
co-immunoprecipitation, si-RNA treatment, and cotransfection with a CMV-TAP expression vector. Fig. 7A. Huh7 cells were transfected
with expression vectors of a) SV40 LT, or b) SV40 LT-HBc ARD chimera. Transfected cell lysates were immunoprecipitated (IP) with anti-SV40 LT
antibody. Equal amounts of immunoprecipitated cell lysates from a) or b) were loaded on SDS-PAGE, respectively, followed by Western blot analysis
using anti-TAP or anti-SV40 LT antibodies. The 66 kDa TAP protein can be detected only in cell lysates transfected with SV40 LT-HBc ARD, but not
transfected with wild type SV40 LT, indicating that TAP could bind to HBc ARD. This result was confirmed in a reciprocal experiment using an anti-TAP
antibody for IP. Fig. 7B. Knockdown of endogenous TAP protein by siRNA against TAP (panel b) resulted in a more than 17-fold increase of nuclear
accumulation of wild type HBc (N.C pattern shifted from 3% to 52%). In contrast, control siRNA (Nontarget) (panel a) did not affect the subcellular
localization pattern of HBc. HBc (red), a-tubulin (green) and DAPI (blue). Fig. 7C. Treatment of Huh7 cells with TAP-specific siRNA resulted in
appreciable reduction of TAP protein by Western blot analysis using anti-TAP antibody. * Non-specific bands served as an internal control. (cf
Materials and Methods for detail). Fig. 7D. The nuclear predominant phenotype of wild type HBc in Huh7 cells treated with siTAP can be reverted
efficiently to a cytoplasmic predominant phenotype by cotransfection with a CMV-TAP expression vector. Fig. 7E. Western blot analysis of TAP
protein in Huh7 cells transfected with a vector only or a plasmid CMV-TAP. Fig. 7F. Upon treatment with siTAP, wild type HBV DNA synthesis in Huh7
cells was reduced approximately 7-fold by Southern blot analysis. RC: relaxed circle DNA, SS: single-strand DNA. While there was no difference in the
results of MTT cytotoxicity assay using media from cell culture with or without siTAP treatment, the HBsAg level by ELISA was reduced by
approximately 10-fold with siTAP treatment. The averaged values of DNA intensity, MTT assay, and HBsAg assay were processed from four
independent experiments (Materials and Methods).
doi:10.1371/journal.ppat.1001162.g007
Table 1. Comparisons of the Subcellular Distribution of HBV Core Protein in the Liver of Hydrodynamically Injected BALB/c Mice
by Immunohistochemical Staining*.
HBc genotypes total number of cells counted C.N (%) C+N (%) N.C (%)
WT 443 25.06 48.53 26.41
864 23.38 50.00 26.62
Mutant ARD -I+III 808 21.29 61.88 16.83
573 29.32 45.90 24.78
Mutant ARD -II+IV 526 8.56 27.38 64.07
603 7.30 46.93 45.77
*For each HBc genotype, two BALB/c mice were injected intravenously, and HBc expression was examined in a double blind manner in sectioned liver samples on day 3
post-injection by IHC using anti-HBc antibody. Definitions of C.N, C+N, and N.C patterns are as described in the legend to Fig. 2.
doi:10.1371/journal.ppat.1001162.t001
Nucleocytoplasmic Shuttling of HBV Core
PLoS Pathogens | www.plospathogens.org 12 October 2010 | Volume 6 | Issue 10 | e1001162could be so different or even opposite (NLS vs. NES/CRS). It is
possible that their functional difference could be related to the
following: 1) their structural differences in amino acid sequences at
the boundary regions of these four ARD subdomains (Fig. 9). For
example, the C-terminal boundary of NES-IV could include
sequences that are absent in NLS-III. 2) HBc is a phosphoprotein
[50] and phosphorylation of serine residues at the boundaries has
been shown to influence nuclear transport of HBc (e.g.,
[25,47,48]), presumably by modulating the activities of NLS and
NES. Conversely, mutations at arginine residues could affect
phosphorylation of adjacent serines. It is possible that posttrans-
lational modification might render ARD-III or ARD–IV exerting
different functions, despite the same amino acid sequences. 3) The
same stretch of amino acid sequences could be folded into different
3D structures or positioned in different contexts of 3D structures.
An example of the dual topology of the preS1 polypeptide of HBV
surface antigen can be cited here [51].
Hierarchy among different trafficking signals
In the transient transfection system, wild type HBc is
predominantly cytoplasmic (Fig. 2). Therefore, HBc NES/CRS
appeared to be dominant over NLS, at least in the transient
transfection assay. However, it is less clear to us at present
concerning the relative strength between NES-II/CRS-II and
NES-IV/CRS-IV. As for the relative strength between NLS-I and
NLS-III, NLS-III appeared to be stronger than NLS-I. When
NLS-I was mutated in mutant ARD- I+II+IV, nuclear HBc could
still be detected in 4–10% of transfected Huh7 cells. Conversely,
when NLS-III was mutated in mutant ARD-II+III+IV, we could
not detect any nuclear HBc (Fig. 2A).
NLS of HBc protein vs. NLS of HBc particles
The C-terminus of HBc has been mapped to the capsid interior
in icosahedral particles [46]. It is therefore unclear how NLS and
NES/CRS in the capsid interior can be recognized by the cellular
machinery involved in nuclear import. Previously, we proposed a
‘‘charge balance hypothesis’’ of HBc capsid stability and assembly
(also coined ‘‘balanced electrostatic interaction hypothesis’’)
[9,10,11]. Alterations of capsid conformation can be triggered
by charge imbalance in the capsid inner surface. When the plus-
strand DNA synthesis begins to accumulate more and more
negative charge from the elongating phosphodiester backbone, it is
postulated that capsid instability would gradually increase, leading
to the change of capsid conformation. When such a charge
imbalance reaches over a certain threshold, the degree of change
of capsid structure would allow the (transient) exposure of the HBc
NLS to capsid exterior. The exposed NLS can then be recognized
by cellular importin, and nuclear transport of HBc protein or
particles can then be facilitated. According to this hypothesis, the
NLS present in chimeric HBc reporters (Fig. 3–6) should be the
same one present in HBc capsid particles with ongoing HBV DNA
replication (Fig. 2).
Previously, we reported that HBc protein in the nucleus can
exist as capsid particles [35], as it can be stained by using a
monoclonal antibody Hyb-3120 specific for HBc capsid confor-
mation [34]. Recently, it has been reported that nuclear entry of
HBc capsids could involve disintegration of capsids to protein
dimers, followed by nuclear reassociation of dimers to capsids [52].
If this scenario is true, the NLS associated with HBc capsids is
likely to be the same one present in HBc protein monomers or
dimers.
Multiple layers of regulation of HBc subcellular
localization
The nuclear targeting behavior of HBc mutant ARD-II+IV in
Huh7 cells is consistent with that in the hydrodynamic mouse
model. However, what could be an explanation for the higher
frequency of nuclear localization of wild type HBc in the
hydrodynamic mouse model (26% N.C pattern, Table 1, vs.
1% N.C pattern, Fig. 2)? We are not sure whether liver injury
caused by the hydrodynamic injection could contribute in part to
this phenomenon. When a control vector without HBV DNA was
used for hydrodynamic injection (data not shown), vacuolating
hepatocytes were often observed near the central vein (like the
vacuolating hepatocytes in Fig. 8). Therefore, hepatic vacuolation
is probably in part due to the physical shearing stress during the
hydrodynamic injection. A similar phenomenon of vacuolating
hepatocytes was observed previously after hydrodynamic delivery
[53,54]. It is also possible that a minor degree of hepatic injury
could cause liver regeneration and mitosis of hepatocytes.
Previously, it has been shown that cell cycling could influence
nuclear localization of HBc in tissue culture [55]. In addition to
the intrinsic factors, such as NLS and NES of HBc, extrinsic
factors, such as inflammation, innate immunity, liver regeneration,
cell cycling, and host factors (such as importin, TAP, cellular
Figure 9. A summary of novel trafficking signals of HBc core
protein and particles identified in this study vs. those reported
previously [23,24,25]. The boundaries between NLS and NES/CRS,
which remain to be defined in the future, are shown by dotted lines.
doi:10.1371/journal.ppat.1001162.g009
Figure 8. In vivo subcellular localization of core proteins
encoded by mutants HBc ARD-I+III and ARD-II+IV was exam-
ined by immunohistochemistry staining and hydrodynamic
delivery. The liver tissue was collected 3 days post injection with the
following plasmids: a) wild type HBc was mainly distributed in the
cytoplasm; b) HBc of mutant ARD-I+III was also mainly distributed in the
cytoplasm; a central vein-like structure is shown near the upper right
corner. c & d) HBc of mutant ARD-II+IV was mainly distributed in the
nucleus; Inflammatory lymphocyte infiltration was noted. Magnification,
640. The relative frequencies of different patterns of subcellular
localization of HBc were scored in a double blind manner (Table 1).
doi:10.1371/journal.ppat.1001162.g008
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extrinsic factors could be quite variable in activities in different
assay systems (e.g., cell culture vs. animal models). Taken together,
these extrinsic and intrinsic factors constitute multiple layers of
regulation of intracellular HBc trafficking. As such, the distribution
of HBc between nucleus and cytoplasm of various mutants is not
simply categorical, but only relative. In this regard, it is
particularly helpful to practice the double blind protocol in IFA
and perform Western blot analysis.
Biological significance of nucleocytoplasmic shuttling of
HBc
TAP is known as a primary receptor for general mRNA export
[28]. Recently, it has been demonstrated that TAP and ICP27
interaction as well as RNA binding by ICP27 are required for
efficient nuclear export of herpes simplex virus 1 transcripts [27].
Similarly, Epstein-Bar virus encodes an early protein EB2 which
contains an NES. This NES contains several small arginine rich
domains which are important for TAP binding and EB2 shuttling
[45]. Both EB2 and ICP27 behaved like a RNA binding adapter
which could facilitate mRNA export by binding to TAP. The
functional significance of nuclear HBc has been a mystery. As
shown in Fig. 10, we speculate that HBc ARD could serve as a
RNA binding adapter for nuclear export of HBV specific
transcripts, based on the following rationales: 1) TAP is a
nucleocytoplasmic shuttling protein [28]. 2) TAP is a known
RNA and protein export receptor [27,28,45]. 3) TAP and HBc
can bind to each other (Fig. 7A). 4) HBc nuclear export depends
on TAP (Fig. 7B). 5) HBc can bind RNA through the ARD [56]. 6)
HBc also appears to be a nucleocytoplasmic shuttling protein
(Fig. 5 and 7B).
As outlined in Fig. 10, mature HBc capsids in the cytoplasm can
import RC DNA into the nucleus, probably by complex
association with the importin machinary. The imported RC
DNA can be converted into covalently closed circular (ccc) DNA,
which in turn serves as a template for pol-II mediated
transcription. HBV pregenomic RNA (pgRNA) in the nucleus
can then be exported to the cytoplasm by TAP and HBc complex.
Translation of cytoplasmic HBV mRNA results in HBc and
polymerase protein. RNA encapsidation of immature capsids
occurs in the cytoplasm by complex association among polymer-
ase, HBc, and pgRNA. Immature capsids gradually grow mature
Figure 10. An intracellular loop of HBV ccc DNA amplification relies on the nucleocytoplasmic shuttling of HBc. RC: relaxed circle DNA,
ccc: covalently closed circle DNA, pol: HBV-encoded polymerase, pol-II: cellular DNA-dependent RNA polymerase II, The nuclear import of HBV RC
DNA, and the nuclear export of HBV pgRNA (pregenomic RNA) could all be facilitated by its dynamically shuttling HBc. Furthermore, an HBc
trafficking hypothesis of acute liver exacerbation assumes that HBV DNA replication and disease activity are significantly suppressed when HBc is
predominantly localized in the nucleus. In contrast, when HBc is predominantly localized in the cytoplasm, HBV DNA replication is activated, and liver
disease activity is elevated.
doi:10.1371/journal.ppat.1001162.g010
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cycle, and build up the ccc DNA pool in the nucleus [8]. The
nucleocytoplasmic shuttling of HBc is thus central to the
intracellular loop of ccc DNA amplification during the life cycle
of HBV.
Correlation between HBV replication and HBc subcellular
localization
In Fig. 2D, both mutant ARD-II+IV and mutant ARD-I+III
can replicate equally well by Southern blot analysis (Fig. 2D),
yet their respective subcellular localizations are opposite to each
other (Fig. 2A and 2B). Therefore, there is no apparent
correlation between HBc subcellular localization and HBV
DNA synthesis. In contrast, in Fig. 7F, knockdown of TAP
resulted in HBc nuclear localization which is correlated with
reduced HBV DNA and HBsAg synthesis. For the lack of a
perfect correlation between nuclear localization of HBc and
reduced viral DNA synthesis, our favorite explanation is that
such a correlation exists only for the wild type-like HBV or its
naturally occurring variants, but not true for artificially
engineered arginine deficient mutants, such as mutant ARD-
I+III or ARD-II+IV. As shown in Fig. 2D, the replication
patterns between WT-HBV and ARD mutants are very
different. The latter has a ‘‘short-DNA phenotype’’ [9,11],
which is absent in wild type HBV. Therefore, while the general
correlation between nuclear localization of HBc and reduced
viral DNA synthesis could hold true for wild-type like variants, it
cannot be applied to engineered ARD mutants with significant
charge imbalance [9,10,11]. In fact, very few naturally
occurring HBc variants contain mutations at the arginine
residues of HBc ARD [57]. The most frequent naturally
occurring mutations of HBc occurred at the capsid assembly
domains of HBc 1–149, particularly at hotspots of amino acids
5, 13, 86, 97, and 130.
Potential clinical significance of HBc nucleocytoplasmic
shuttling
To date, the molecular mechanism of acute exacerbation of
chronic hepatitis B has remained unclear [58]. Similarly, the
molecular mechanism of spontaneous relapse of hepatitis in
asymptomatic HBsAg carriers has remained to be elucidated [59].
Here, we hypothesize that the unleash of HBc from nucleus to
cytoplasm can be triggered by some unknown extrinsic factors,
leading to the reactivation of HBV replication in the cytoplasm of
hepatocytes and thus a new wave of immune attack and cytolysis
from host defense (Fig. 10). In this context, we envision the nucleus
as a reservoir for HBV genome and an ‘‘immune privileged site’’
for the shuttling HBV core protein.
Accession numbers/ID numbers for genes and proteins
mentioned in the text
The accession numbers in GenBank for hepatitis B virus (ayw)i s
V01460, in Entrez Gene for TAP/NXF1 is 10482, for SV40 LT is
1489531, for HIV-1 Rev is 155908, and in UniProtKB/Swiss-Prot
for TAP/NXF1 is Q9UBU9, for SV40 LT is P03070, for HIV-1
Rev is P69718.
Supporting Information
Figure S1 HBc ARD can function like a CRS (cytoplasmic
retention signal). (A) Heterokaryon analysis suggests efficient
nuclear import of wild type Rev protein (green) from transfected
human cells (arrowhead) to untransfected mouse nuclei (arrow).
Mouse nuclei can be differentiated from human nuclei by their
brighter DAPI blue staining pattern. (B) Heterokaryon analysis
suggests the lack of efficient nuclear import of Rev-HBc ARD
chimera protein (green) from transfected human cells (arrowhead)
to untransfected mouse nuclei (arrow). Mouse nuclei can be
differentiated from human nuclei by their brighter DAPI blue
staining pattern. HBc ARD can function like a CRS.
Found at: doi:10.1371/journal.ppat.1001162.s001 (5.26 MB TIF)
Figure S2 HBc ARD can function like an NES (nuclear export
signal). SV40 LT is a nuclear protein which contains an NLS, but
without any NES. Heterokaryon analysis suggests efficient
transport of SV40LT-HBc ARD chimera protein from transfected
human cells to untransfected mouse nuclei. arrowhead: human
Huh7 cells transfected with SV40LT-HBc ARD chimera; arrow:
unstransfected mouse NIH3T3 cells with a much brighter DAPI
blue staining pattern characteristic of mouse origin.
Found at: doi:10.1371/journal.ppat.1001162.s002 (2.55 MB TIF)
Figure S3 HBc ARD can function as a CRS or NES, depending
on the relative strength between NLS and NES in the same
context. (A) SV40 LT is a nuclear protein which contains an NLS,
but without any NES. Upon fusion with HBc ARD, the chimera of
SV40LT-HBc can be transported from transfected human to
untransfected mouse nuclei by heterokaryon analysis. Arrowhead:
human Huh7 cells cotransfected with SV40LT-HBc ARD
chimera (red) and wild type Rev (green); arrow: unstransfected
mouse NIH3T3 cells with mouse characteristic brighter DAPI
blue staining. (B) Heterokaryon analysis suggests that SV40LT-
HBc chimera can be transported from transfected human to
untransfected mouse nuclei. This result suggests the existence of an
NES in HBc ARD. In contrast, Rev-HBc is localized only to the
cytoplasm, suggesting the existence of a CRS in HBc ARD. We
speculate that the same HBc ARD can function as a CRS or NES
depending on the relative strength between NLS and NES in the
same context. Arrowhead: human Huh7 cells cotransfected with
SV40LT-HBc chimera (red) and Rev-HBc chimera (green).
Arrow: unstransfected mouse NIH3T3 cells with mouse charac-
teristic brighter DAPI blue staining.
Found at: doi:10.1371/journal.ppat.1001162.s003 (4.73 MB TIF)
Figure S4 The NES of HBc ARD is associated with ARD-II and
ARD-IV. Heterokaryon analysis: Huh7 cells transfected with
SV40LT-HBc ARD-II+IV chimera were fused with NIH-3T3
cells. Lack of transport from human to mouse nuclei was noted.
This result suggests that the NES of HBc resides in ARD-II and
ARD-IV. Arrowhead: human Huh7 cells transfected with
SV40LT-HBc ARD-II+IV (green). Arrow: unstransfected mouse
NIH3T3 cells with mouse characteristic brighter DAPI blue
staining.
Found at: doi:10.1371/journal.ppat.1001162.s004 (2.26 MB TIF)
Figure S5 The subcellular distribution of the Rev protein is
insensitive to the treatment with si-TAP. Treatment with siRNA
specific for TAP has no significant effect on the subcellular
localization of wild type Rev protein in Huh7 cells transfected with
plasmid pCMV-Rev (green). This result served as a control to
Fig. 7B, and it argues for a specific effect of si-TAP treatment on
the nuclear accumulation of HBc protein in Huh7 cells transfected
with a wild type HBV replicon pCH93091 in Fig. 7B.
Found at: doi:10.1371/journal.ppat.1001162.s005 (0.60 MB TIF)
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